Skip to main content

ICPE 2022 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Whitney Krueger, PhD

AbbVie
North Chicago, Illinois, United States

AbbVie (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

Predictors of Effectiveness of First-line Biologic Disease Modifying Antirheumatic Drug(s) (bDMARD) or Targeted Synthetic DMARD (tsDMARD) Treatment with a Tumor Necrosis Factor Inhibitor in Patients with Rheumatoid Arthritis
Saturday, August 27, 2022
1:30 PM – 1:35 PM CEST